JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kurabachew, M.
Right arrow Articles by Ryon, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kurabachew, M.
Right arrow Articles by Ryon, J. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 1998, p. 1352-1356, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Reverse Transcription-PCR Detection of Mycobacterium leprae in Clinical Specimens

Mekonnen Kurabachew,1,2 Assefa Wondimu,1 and Judith J. Ryon1,3,*

Armauer Hansen Research Institute1 and Department of Biology, Addis Ababa University,2 Addis Ababa, Ethiopia, and Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland3

Received 16 July 1997/Returned for modification 4 November 1997/Accepted 15 January 1998

A reverse transcription (RT)-PCR assay targeting the 16S rRNA of Mycobacterium leprae was developed to detect the organism in clinical specimens. A 171-bp fragment was amplified when M. leprae RNA was used as a template but not when a panel of RNAs from 28 potentially cross-reacting mycobacterial species, seven genera related to Mycobacterium, and three organisms normally found among skin or nose flora were tested. As few as 10 organisms isolated from infected tissue could be detected, confirming the sensitivity of the assay. When the test was applied to clinical specimens, M. leprae was detected in 82% of skin biopsy specimens obtained from untreated leprosy patients, while skin biopsy specimens from healthy volunteers and patients with other dermatological disorders were negative. The sensitivity of the RT-PCR was higher than that of slit skin smear staining for acid-fast bacilli or acid-fast staining of fixed biopsy specimens since 53% of acid-fast bacillus-negative biopsy specimens were RT-PCR positive. Because 16S rRNA is rapidly degraded upon cell death, the assay may detect only viable organisms and may prove to be useful in assessing the efficacy of chemotherapy.

* Corresponding author. Mailing address: Department of Neurology, Johns Hopkins University School of Medicine, Pathology 509, 600 North Wolfe St., Baltimore, MD 21287. Phone: (410) 955-3794. Fax: (410) 614-1008. E-mail: jryon{at}welchlink.welch.jhu.edu.

Journal of Clinical Microbiology, May 1998, p. 1352-1356, Vol. 36, No. 5
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 1998 by the American Society for Microbiology. All rights reserved.